Summary: Rasagiline is a novel, investigational propargylamine that irreversibly and selectively inhibits monoamine oxidase type B (MAO-B). Rasagiline demonstrates complete and selective ...

Mathew B, Haridas A, Uçar G, Baysal I, Adeniyi AA, Soliman ME, et al.. Exploration of Chlorinated Thienyl Chalcones: A New Class of Monoamine Oxidase-B Inhibitors. International Journal of Biological ...

Persson, T., and Roos, B.-E., Lancet, ii, 987 (1967). Coppen, A., Shaw, D. M., Herzberg, B., and Maggs, R., Lancet, ii, 1178 (1967). Sjoerdsma, A., Oates, J. A ...

China releases its biggest 10 scientific advances of 2024, including space, health, and quantum research at Zhongguancun Forum (ZGC Forum).

A new brain imaging study has revealed that lysergic acid diethylamide (LSD) alters brain connectivity in ways that are ...

Announcing a new publication for Acta Materia Medica journal. Monoamine oxidase (MAO) is a useful target in the treatment of neurodegenerative diseases and depressive disorders. Understanding the ...

Antidepressant discontinuation syndrome can cause symptoms such as nausea, headaches, diarrhea, or even reoccurrence of ...

Department of Pharmacy, Quaid-i-Azam University, Islamabad 45320, Pakistan Department of Chemistry, Quaid-i-Azam University, Islamabad 45320, Pakistan ...

If you’ve been diagnosed with major depressive disorder or a form of anxiety, your mental health provider may prescribe the ...

Of the 103 patients who completed the Phase III trial, more than half witnessed remission from a drug-induced condition that ...

The companies are striving to bring fresh innovations to cancer care, pain management and the weight loss space.